These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


150 related items for PubMed ID: 130347

  • 1. A cost-effectiveness model for evaluating health care programs: application to drug abuse treatment.
    Goldschmidt PG.
    Inquiry; 1976 Mar; 13(1):29-47. PubMed ID: 130347
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of treatment for drug abuse.
    Sells SB.
    Proc Natl Conf Methadone Treat; 1973 Mar; 2():1362-8. PubMed ID: 4808289
    [No Abstract] [Full Text] [Related]

  • 3. Evaluating drug abuse treatment: a comment on the state of the art.
    Jaffe JH.
    NIDA Res Monogr; 1984 Mar; 51():13-28. PubMed ID: 6095081
    [No Abstract] [Full Text] [Related]

  • 4. The effectiveness of drug treatment.
    Gerstein DR.
    Res Publ Assoc Res Nerv Ment Dis; 1992 Mar; 70():253-82. PubMed ID: 1311121
    [No Abstract] [Full Text] [Related]

  • 5. The cost-effectiveness of methadone maintenance.
    Barnett PG, Hui SS.
    Mt Sinai J Med; 2000 Mar; 67(5-6):365-74. PubMed ID: 11064486
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Drug abuse programs: are hospitals too late and too square?
    Philips DF.
    Hospitals; 1971 Jan 16; 45(2):55-60. PubMed ID: 5123315
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. On the effectiveness of treatment for drug abuse: evidence from the DARP research programme in the United States.
    Sells SB, Simpson DD.
    Bull Narc; 1979 Jan 16; 31(1):1-11. PubMed ID: 260891
    [No Abstract] [Full Text] [Related]

  • 11. Hospitals coordinate chemical abuse programs.
    Malloy JM.
    Hospitals; 1974 Oct 16; 48(20):59-62. PubMed ID: 4413701
    [No Abstract] [Full Text] [Related]

  • 12. Treatment facilities for drug-dependent patients. Some impressions of treatment programmes in the United States and Canada.
    Jensen GR.
    Med J Aust; 1973 Apr 21; 1(16):808-12. PubMed ID: 4707801
    [No Abstract] [Full Text] [Related]

  • 13. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.
    J Ment Health Policy Econ; 2007 Mar 21; 10(1):3-13. PubMed ID: 17417043
    [Abstract] [Full Text] [Related]

  • 14. Heroin addiction: a treatable disease.
    Krepick DS, Long BL.
    Nurs Clin North Am; 1973 Mar 21; 8(1):41-52. PubMed ID: 4487808
    [No Abstract] [Full Text] [Related]

  • 15. The costs of crime and the benefits of drug abuse treatment: a cost-benefit analysis using TOPS data.
    Harwood HJ, Hubbard RL, Collins JJ, Rachal JV.
    NIDA Res Monogr; 1988 Mar 21; 86():209-35. PubMed ID: 3140032
    [No Abstract] [Full Text] [Related]

  • 16. Methadone treatment versus therapeutic communities: preliminary results of a randomized study in progress.
    Bale RN, Van Stone WW, Kuldau JM, Engelsing TM, Zarcone VP.
    Proc Natl Conf Methadone Treat; 1973 Mar 21; 2():1027-34. PubMed ID: 4808243
    [No Abstract] [Full Text] [Related]

  • 17. The natural history of narcotic drug addiction.
    Vaillant GE.
    Semin Psychiatry; 1970 Nov 21; 2(4):486-98. PubMed ID: 5527413
    [No Abstract] [Full Text] [Related]

  • 18. A profile of the substance abuse treatment industry: organization, costs, and treatment completion.
    Woodward AM, Raskin IE, Blacklow B.
    Subst Use Misuse; 2008 Nov 21; 43(5):647-79. PubMed ID: 18393082
    [Abstract] [Full Text] [Related]

  • 19. [Social and medical assistance for drug addicts].
    Marinelli M, Fresa U, D'Agostino M, Ruoppo G.
    Arch Monaldi; 1981 Nov 21; 36(1-2):3-8. PubMed ID: 6982695
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of drug abuse treatment and rehabilitation programs.
    Doran R.
    Proc Natl Conf Methadone Treat; 1973 Nov 21; 2():1374-8. PubMed ID: 4808291
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.